WallStSmart

ASP Isotopes Inc. Common Stock (ASPI)vsSherwin-Williams Co (SHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 79021% more annual revenue ($24.41B vs $30.85M). SHW leads profitability with a 11.0% profit margin vs 0.0%. SHW earns a higher WallStSmart Score of 60/100 (C+).

ASPI

Avoid

32

out of 100

Grade: F

Growth: 6.3Profit: 2.5Value: 6.7Quality: 5.5
Piotroski: 4/9Altman Z: -0.12

SHW

Buy

60

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASPIUndervalued (+77.6%)

Margin of Safety

+77.6%

Fair Value

$25.34

Current Price

$3.31

$22.03 discount

UndervaluedFair: $25.34Overvalued
SHWUndervalued (+2.3%)

Margin of Safety

+2.3%

Fair Value

$330.90

Current Price

$323.31

$7.59 discount

UndervaluedFair: $330.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASPI2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
327.6%10/10

Revenue surging 327.6% year-over-year

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

SHW3 strengths · Avg: 9.0/10
Return on EquityProfitability
69.7%10/10

Every $100 of equity generates 70 in profit

Market CapQuality
$78.49B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

Areas to Watch

ASPI4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$507.45M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Debt/EquityHealth
1.023/10

Elevated debt levels

SHW4 concerns · Avg: 3.5/10
PEG RatioValuation
2.054/10

Expensive relative to growth rate

P/E RatioValuation
29.3x4/10

Moderate valuation

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Price/BookValuation
20.2x2/10

Trading at 20.2x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : ASPI

The strongest argument for ASPI centers on Revenue Growth, Price/Book. Revenue growth of 327.6% demonstrates continued momentum.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap, Free Cash Flow.

Bear Case : ASPI

The primary concerns for ASPI are EPS Growth, Market Cap, Profit Margin.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, Altman Z-Score. Debt-to-equity of 3.69 is elevated, increasing financial risk.

Key Dynamics to Monitor

ASPI profiles as a hypergrowth stock while SHW is a value play — different risk/reward profiles.

ASPI carries more volatility with a beta of 3.60 — expect wider price swings.

ASPI is growing revenue faster at 327.6% — sustainability is the question.

SHW generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

SHW scores higher overall (60/100 vs 32/100). ASPI offers better value entry with a 77.6% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ASP Isotopes Inc. Common Stock

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?